Harvard University offers a free course on Buddhist scriptures.
Scientists at the food giant reportedly found a novel way of altering the molecular structure of sugar.
A massive chart of humankind’s 113 spacecraft so far and where they’ve gone.
New studies from NYU and John Hopkins University show the effectiveness of psilocybin in treating depression and anxiety of cancer patients.
The results of one Stanford study has implications for art, politics, law, even religion.
Jon Stewart shares his thoughts on many issues during a recent talk with the New York Times.
Few see how strongly science's preferred languages shape and limit the thinking of many experts.
Spontaneous talk on surprise topics. Artist David Salle on how even to begin figuring out what "works" in art.
It seems inevitable that there will be a Mars colony, but the path there won't be easy. There are two key challenges ahead that will push innovation.
A rash of teen idols, singers, actors, and actresses have all come out recently detailing their struggles.
A researcher is experimenting with an artificial hippocampus to learn how to strengthen and store memories.l
New research at MIT might be a game-changer for Alzheimer's. But you don't have to wait to strengthen your brain's memory system.
Poor Americans, people in rural locations, and those with disabilities would benefit most.
Millions of Muslims marched to Karbala, Iraq even after suicide bombing and continued threats by ISIL. The Arbaeen pilgrimage continues to be a show of religious freedom.
Artificial intelligence (AI) is not nearly as smart as we want it to be. Because we are not nearly as smart as we want to be.
In spite of rumors, billionaire Corona beer founder Antonino Fernández's estate will not be distributed among the residents of his home town.
Researchers scan the brains of people having strong spiritual experiences.
The surgeon general is pleading for a fundamental shift in how we think about addiction.
As the US prepares for a change in power, Professor Sanford Levinson says dialogue that was formerly bound to people's inner monologue has been "liberated" into the public space.
The first clinical trials on humans of CRISPR-Cas9-edited genes has begun in China.